# Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose

> **NCT01692158** · PHASE1 · COMPLETED · sponsor: **Azidus Brasil** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Heparin, Low-Molecular-Weight

## Key facts

- **NCT ID:** NCT01692158
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01692158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01692158, "Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01692158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*